Brazil’s health watchdog said Monday it opposes the import of the Russian-made Sputnik V vaccine into several states because it believes the vaccine lacks data that would guarantee its safety and medical efficacy.
Antonio Barra Torres, head of Brazil’s health regulator, said, “We will never allow millions of Brazilians to be exposed to a product that has not been validated for proper quality, safety and efficacy, or at least a risk-benefit relationship in the face of the dire situation we are experiencing. A good and satisfactory relationship”. The head of the Brazilian health regulator, following the advice of its experts, pointed out the “uncertainty” regarding the Russian vaccine, which has not yet been approved by the health agencies of the European Union (EMA) and the United States (FDA).
Meanwhile, India approved the Russian vaccine Sputnik V on Tuesday amid an emergency caused by an outbreak of new cases and hopes to fill the delay in the vaccination campaign. The European Union’s health unit (EMA) will not rush to speed up the approval, but will continue its validation approval process that began in March, with the EU likely to publish the results of the validation verdict in June. And several EU countries, including Germany and Austria, have already booked millions of doses.
The government of Hungarian Prime Minister Viktor Orban has not waited for approval from EU health regulators and has been using the Russian vaccine since February.
The EU is facing serious delays in the delivery of AstraZeneca vaccines, and Germany and Austria may decide on the use of Russian vaccines with individual national positions.
Recent Comments